# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-123423
Filing Date
2024-11-07
Accepted
2024-11-07 16:30:29
Documents
76
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | adpt-20240930.htm iXBRL | 10-Q | 2529170
2 | EX-31.1 | adpt-ex31_1.htm | EX-31.1 | 17620
3 | EX-31.2 | adpt-ex31_2.htm | EX-31.2 | 17614
4 | EX-32.1 | adpt-ex32_1.htm | EX-32.1 | 10512
5 | EX-32.2 | adpt-ex32_2.htm | EX-32.2 | 11683
| Complete submission text file | 0000950170-24-123423.txt |  | 10157860

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | adpt-20240930.xsd | EX-101.SCH | 1195605
79 | EXTRACTED XBRL INSTANCE DOCUMENT | adpt-20240930_htm.xml | XML | 2071417

Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 241436350
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)